SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin

INTRODUCTION: Patients with primary or secondary immunodeficiency (PID or SID) face increased insecurity and discomfort in the light of the COVID-19 pandemic, not knowing if and to what extent their comorbidities may impact the course of a potential SARS-CoV-2 infection. Furthermore, recently availa...

Descripción completa

Detalles Bibliográficos
Autores principales: Volk, Andreas, Covini-Souris, Caroline, Kuehnel, Denis, De Mey, Christian, Römisch, Jürgen, Schmidt, Torben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628143/
https://www.ncbi.nlm.nih.gov/pubmed/34843105
http://dx.doi.org/10.1007/s40259-021-00511-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628143/
https://www.ncbi.nlm.nih.gov/pubmed/34843105
http://dx.doi.org/10.1007/s40259-021-00511-9

Ejemplares similares